Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-16
DOI
10.3389/fimmu.2020.620098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Ruxolitinib Cream on Pruritus and Quality of Life in Atopic Dermatitis: Results From a Phase 2, Randomized, Dose-Ranging, Vehicle- and Active-Controlled Study
- (2020) Brian S. Kim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Type 2 immunity in the skin and lungs
- (2020) Cezmi A. Akdis et al. ALLERGY
- Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
- (2020) Madan Jagasia et al. BLOOD
- Sleep disturbance in atopic dermatitis: a case–control study using actigraphy and smartphone‐collected questionnaires
- (2020) M. Jachiet et al. BRITISH JOURNAL OF DERMATOLOGY
- Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
- (2020) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human skin explant model for the investigation of topical therapeutics
- (2020) Jessica E. Neil et al. Scientific Reports
- JAK/STAT inhibitors for the treatment of atopic dermatitis
- (2019) Maria Alexandra Rodrigues et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- IL-33-induced atopic dermatitis-like inflammation in mice is mediated by group 2 innate lymphoid cells in concert with basophils
- (2019) Yasutomo Imai et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- T cell pathology in skin inflammation
- (2019) Robert Sabat et al. Seminars in Immunopathology
- Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream
- (2019) Brian S. Kim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-33 in atopic dermatitis
- (2019) Yasutomo Imai JOURNAL OF DERMATOLOGICAL SCIENCE
- Atopic dermatitis epidemiology and unmet need in the United Kingdom
- (2019) Michael J. Cork et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- (2019) Michael D. Howell et al. Frontiers in Immunology
- JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease
- (2018) Michael D. Howell et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Atopic dermatitis: the skin barrier and beyond
- (2018) T. Tsakok et al. BRITISH JOURNAL OF DERMATOLOGY
- Emerging therapies for atopic dermatitis: JAK inhibitors
- (2018) David G. Cotter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- “To Cope with Everyday Life, I Need to Sleep” – A Phenomenographic Study Exploring Sleep Loss in Parents of Children with Atopic Dermatitis
- (2018) Charlotte Angelhoff et al. Journal of Pediatric Nursing-Nursing Care of Children & Families
- Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model
- (2018) Tomoki Fukuyama et al. BMC Pharmacology & Toxicology
- A network map of IL-33 signaling pathway
- (2018) Sneha M. Pinto et al. Journal of Cell Communication and Signaling
- Atopic dermatitis
- (2018) Stephan Weidinger et al. Nature Reviews Disease Primers
- Voluntary wheel running: patterns and physiological effects in mice
- (2018) G. Manzanares et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- New Cytokines in the Pathogenesis of Atopic Dermatitis—New Therapeutic Targets
- (2018) Jolanta Klonowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Itch: From mechanism to (novel) therapeutic approaches
- (2018) Gil Yosipovitch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Inhibition of JAK/STAT pathway restrains TSLP-activated dendritic cells mediated inflammatory T helper type 2 cell response in allergic rhinitis
- (2017) Zhaohui Shi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
- (2017) Brad Griesenauer et al. Frontiers in Immunology
- Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
- (2016) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
- (2016) Jeffrey C. Bryan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Evolution of Cytokine Receptor Signaling
- (2016) Clifford Liongue et al. JOURNAL OF IMMUNOLOGY
- IL-33 impacts on the skin barrier by downregulating the expression of filaggrin
- (2015) Jenny Seltmann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Innate Lymphoid Cells in the Skin
- (2015) Brian S. Kim JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-7 and TSLP receptors: twisted sisters
- (2014) S. K. Durum BLOOD
- TSLP Induces Mast Cell Development and Aggravates Allergic Reactions through the Activation of MDM2 and STAT6
- (2014) Na-Ra Han et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic Dermatitis, Melatonin, and Sleep Disturbance
- (2014) Y.-S. Chang et al. PEDIATRICS
- T-Helper Type-2 Contact Hypersensitivity of Balb/c Mice Aggravated by Dibutyl Phthalate via Long-Term Dermal Exposure
- (2014) Jinquan Li et al. PLoS One
- TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling
- (2014) J. Zhong et al. Database-The Journal of Biological Databases and Curation
- The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
- (2013) Sarah R. Wilson et al. CELL
- Role of Interleukin 1 in Atopic Dermatitis
- (2013) William Abramovits et al. DERMATOLOGIC CLINICS
- Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice
- (2013) Yasutomo Imai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TSLP Elicits IL-33-Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation
- (2013) B. S. Kim et al. Science Translational Medicine
- The many faces of Janus kinase
- (2011) Matthew M. Seavey et al. BIOCHEMICAL PHARMACOLOGY
- Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling
- (2010) Y. Rochman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MMP19 Is Essential for T Cell Development and T Cell-Mediated Cutaneous Immune Responses
- (2008) Inken M. Beck et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More